Palisade Bio
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $4 | $0 |
Gross Profit | -1 | -1 | 2 | -1 |
EBITDA | -2,781 | -2,228 | -3,341 | -3,480 |
EBIT | -2,782 | -2,229 | -3,338 | -3,481 |
Net Income | -2,784 | -2,230 | -3,344 | -3,487 |
Net Change In Cash | 0 | 0 | 4 | 0 |
Free Cash Flow | -1,817 | -2,333 | -2,381 | -3,133 |
Cash | 5,417 | 7,230 | 9,821 | 8,040 |
Basic Shares | 4,797 | 4,796 | 8,540 | 5,818 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $250 | $250 | $0 |
Gross Profit | -3 | 250 | -167 | -168 |
EBITDA | -14,859 | -12,281 | -15,150 | -24,050 |
EBIT | -14,450 | -12,285 | -15,317 | -24,218 |
Net Income | -14,438 | -12,300 | -14,260 | -26,616 |
Net Change In Cash | 0 | 250 | 250 | 0 |
Free Cash Flow | -12,193 | -11,137 | -13,370 | -14,773 |
Cash | 9,821 | 12,432 | 12,383 | 10,495 |
Basic Shares | 1,416 | 456 | 880 | 186 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.58 |
2025-03-31 | -$0.47 |
2024-12-31 | -$0.69 |
2024-09-30 | -$2.32 |
